Neomycin And Polymyxin B Sulfates And Hydrocortisone
Product Images NDC 76413-117

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Hydrocortisone (NDC 76413-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Central Texas Community Health Centers, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neomycin Sulfate (structural Formula) (A5f50a91 45db 4de0 8cfb Dfd33da7475f 01)

Chemical structure diagram showing the molecular structure of neomycin B and neomycin C components, including their specific R group variations. The diagram also indicates the composition with sulfuric acid (H2SO4). This structure relates to the active ingredient neomycin in the product Neomycin and Polymyxin B Sulfates and Hydrocortisone.*

FDA Label Image

Polymyxin B Sulfate (structural Formula) (A5f50a91 45db 4de0 8cfb Dfd33da7475f 02)

Chemical structure diagram showing components of Neomycin and Polymyxin B Sulfates and Hydrocortisone, including the amino acid sequence with DAB, THR, PHE, LEU residues and the chemical groups of Polymyxin B1 and B2 with methylhexyl side chains, and a sulfate group (xH2SO4).*

FDA Label Image

Hydrocortisone (structural Formula) (A5f50a91 45db 4de0 8cfb Dfd33da7475f 03)

Chemical structure of the active ingredient in Neomycin and Polymyxin B Sulfates and Hydrocortisone. The image depicts the molecular framework with labeled functional groups including hydroxyl, ketone, and methyl groups typical of hydrocortisone's steroid structure.*

FDA Label Image

Principal Display Panel (10 ML Bottle Label)

A medication instruction sheet for Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension 10 mL from Central Texas Community Health Centers. It includes dosing instructions to instill 4 drops in the affected ear(s) three times a day for seven days, with a 'Shake Well' notice. Information is provided in both English and Spanish, along with placeholders for Date, Name, and Doctor. The label references Bausch & Lomb as the manufacturer and shows a batch, lot, and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.